Skip to main content
Supplement ScienceSupplementScience

Benefits of Noopept

Evidence:Emerging
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Memory enhancement — Noopept facilitates all stages of memory processing: acquisition, consolidation, and retrieval, through modulation of glutamatergic neurotransmission at AMPA and NMDA receptors
  • Neurotrophic factor expression — Noopept increases BDNF and NGF levels in the hippocampus and cortex, promoting neuronal survival and plasticity (Ostrovskaya et al., 2007)
  • Neuroprotection — in vitro and animal studies show Noopept protects neurons against amyloid-beta toxicity, oxidative stress, and calcium overload, with implications for neurodegenerative disease prevention
  • Cognitive restoration — Gudasheva et al. (1997) demonstrated that Noopept restored cognitive function in animal models of brain damage at doses 1000x lower than piracetam
  • Anxiolytic effects — some users and small studies report mild anxiety reduction at standard doses, likely mediated through AMPA receptor modulation and neurotrophin expression

What the Research Says

Noopept was developed at the Russian Academy of Medical Sciences and has been extensively studied in Russian clinical literature. Ostrovskaya et al. (2008) demonstrated that chronic administration of Noopept increases brain-derived neurotrophic factor (BDNF) expression in the rat hippocampus, suggesting potential neuroprotective effects against Alzheimer's disease. Additionally, Gudasheva et al. (1997) established its high potency, with Noopept being 1000 times more potent than piracetam by weight. The study revealed that Noopept acts as a prodrug, converting into cyclo-L-prolylglycine in the rat brain, which increases its concentration 2.5-fold compared to piracetam.

Russian clinical trials have shown cognitive benefits of Noopept in patients with mild cognitive impairment and post-stroke cognitive deficits. Ostrovskaya et al. (2014) further explored its neuroprotective effects, highlighting its potential role in mitigating Alzheimer's disease-related mechanisms both in vitro and in vivo. However, Western clinical trials remain limited, with most evidence derived from preclinical models and Russian studies.

Related Conditions

Brain FogFocus
Full Noopept Guide

References

  1. Ostrovskaya RU, Vakhitova YV, Kuzmina USh, et al. (2014). Neuroprotective effect of novel cognitive enhancer noopept on AD-related mechanisms in vitro and in vivo. Experimental Neurology. DOI
  2. AnimalOstrovskaya RU, Gudasheva TA, Zaplina AP, et al. (2008). Noopept stimulates the expression of NGF and BDNF in rat hippocampus. Bulletin of Experimental Biology and Medicine. DOI PubMed
  3. AnimalGudasheva TA, Boyko SS, Ostrovskaya RU, et al. (1997). The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine. European Journal of Drug Metabolism and Pharmacokinetics. DOI PubMed